largest
studi
date
show
preval
elev
aminotransferas
bilirubin
peopl
fare
worst
least
doubl
other
although
clinic
signific
liver
dysfunct
quantifi
studi
led
suggest
find
might
present
clinic
challeng
close
inspect
avail
data
support
higher
preval
abnorm
aminotransferas
level
sever
diseas
studi
actual
suggest
clinic
signific
liver
injuri
uncommon
even
data
sever
ill
patient
select
tabl
although
high
level
posit
end
expiratori
pressur
contribut
hepat
congest
increas
right
atrial
pressur
imped
venou
return
data
suggest
mani
patient
admit
hospit
liver
blood
test
abnorm
without
mechan
ventil
furthermor
distribut
aminotransferas
level
among
patient
support
hypox
hepat
common
phenomenon
accord
publish
literatur
druginduc
liver
injuri
possibl
contribut
factor
observ
abnorm
liver
blood
test
abnorm
therapeut
begin
consid
clinician
mild
liver
test
derang
present
baselin
mani
patient
signific
medic
use
sever
studi
report
elev
level
creatinin
kinas
lactat
dehydrogenas
myoglobin
associ
sever
tabl
therefor
possibl
aminotransferas
elev
necessarili
aris
liver
alon
infect
might
induc
myositi
similar
observ
sever
influenza
infect
propos
caus
direct
liver
injuri
via
viral
hepat
believ
altern
explan
first
derang
liver
function
clearli
mild
second
liver
function
test
patient
differ
durat
symptom
examin
evid
later
present
associ
greater
liver
function
derang
postmortem
liver
biopsi
patient
show
microvesicular
steatosi
common
find
sepsi
importantli
respiratori
virus
produc
similar
elev
liver
function
biomark
thought
relat
hepat
damag
immun
interact
involv
intrahepat
cytotox
cell
kupffer
cell
phenomenon
wax
wane
parallel
respiratori
viral
diseas
absenc
hepat
viral
replic
might
explain
wors
outcom
seen
patient
chronic
liver
diseas
outcom
data
tabl
hepat
dysfunct
sever
accompani
greater
activ
coagul
fibrinolyt
pathway
rel
depress
platelet
count
climb
neutrophil
count
neutrophil
lymphocyt
ratio
high
ferritin
level
although
marker
seen
nonspecif
marker
inflamm
believ
fit
paradigm
diseas
sever
coincid
failur
innat
immun
regul
unbalanc
immun
favour
netosi
coagul
activ
possibl
also
alter
system
iron
metabol
secondari
macrophag
activ
notabl
alter
immun
balanc
occur
increas
age
older
patient
might
therefor
expect
fare
wors
greater
relianc
pathway
clinician
complac
risk
patient
chronic
liver
diseas
cirrhosi
patient
poor
immun
function
wors
outcom
acut
respiratori
distress
syndrom
rest
critic
ill
popul
howev
believ
collater
liver
damag
viral
induc
cytotox
cell
induct
dysregul
innat
immun
respons
probabl
explan
associ
derang
liver
marker
diseas
sever
furthermor
suspect
term
hepat
damag
predominantli
clinic
distract
urg
clinician
scientif
commun
focu
attent
toward
viral
control
modul
innat
immun
dysfunct
declar
compet
interest
mansoor
n
bangash
jaimin
patel
dhruv
parekh
mansoorbangash
uhbnhsuk
